Im like: Whats next
Trends Biomedical Eng
It's important to have open and honest communication with your healthcare provider about your preferences, concerns, and any side effects you might be worried about
With the development of the first GIP/GLP-1 co-agonist, tirzepatide, there has been an exponential increase in the effectiveness of incretin-mimetic pharmacological therapy for weight control in obese patients with and without diabetes
"Pharmacokinetics of high doses of cyanocobalamin administered by intravenous injection for 26 weeks in rats"
doi: 10.3803/EnM.2021.102 Summary Keywords GLP-1 receptor agonists, endocrine, cardiovascular, neurological, cancer Citation Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y and Zhang Y (2021) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects